-
平臺編號：bio-69353
-
國際編號：CRL-2020
-
細胞信息： DBTRG-05MG
-
規(guī)格：Frozen
-
用途：ATCC原裝細胞
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
DBTRG-05MG
器官來源：大腦
細胞形態(tài)：成纖維樣
生長狀態(tài)：貼壁生長
年限：59 years
數(shù)量：大量
運輸方式：凍存運輸
細胞類型：其他細胞類型
ATCC Number：CRL-2020?
相關疾?。浩渌膊?br /> 是否是腫瘤細胞：1
物種來源：人
規(guī)格：60 次 Designations: DBTRG-05MG
Depositors: ?CA Kruse
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Homo sapiens
Morphology:fibroblast
Source: Organ: brain
Disease: glioblastoma
Cell Type: glial cell;
Cellular Products:vimentin; S-100 protein; neuron specific enolase
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Receptors:epidermal growth factor (EGF)
Antigen Expression:Class I antigen expressed
DNA Profile (STR):Amelogenin: X
CSF1PO: 10,11
D13S317: 9
D16S539: 10,12
D5S818: 12,13
D7S820: 11
THO1: 7,8
TPOX: 8
vWA: 15,16
Cytogenetic Analysis:near tetraploid; range 87 to 91; most cells were missing copies of chromosome 10 and had extra copies of chromosome 7
Age: 59 years
Gender: female
Ethnicity: Caucasian
Comments:The DBTRG-O5MG (Denver Brain Tumor Research Group 05) cell line was established from tissue from a patient with glioblastoma multiforme who had been treated with local brain irradiation and multidrug chemotherapy.
The cells are negative for platelet derived growth factor (PDGF), neuronal cell adhesion molecule (NCAM), glial fibrillary acid protein (GFAP) and class II antigen (HLA DR).
No loss of heterozygosity in the p53 tumor suppressor gene was detected.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium:
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium, add fresh 0.25% trypsin, rinse and remove trypsin. Let the flask sit at room temperature (or incubate at 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks.
References: 24397: Kruse CA, et al. Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell. Dev. Biol. 28A: 609-614, 1992. PubMed: 1331021
32274: Koochekpour S, et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57: 5391-5398, 1997. PubMed: 9393765
32550: Debinski W, et al. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. J. Biol. Chem. 271: 22428-22433, 1996. PubMed: 8798406
細胞形態(tài)：成纖維樣
生長狀態(tài)：貼壁生長
年限：59 years
數(shù)量：大量
運輸方式：凍存運輸
細胞類型：其他細胞類型
ATCC Number：CRL-2020?
相關疾?。浩渌膊?br /> 是否是腫瘤細胞：1
物種來源：人
規(guī)格：60 次 Designations: DBTRG-05MG
Depositors: ?CA Kruse
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Homo sapiens
Morphology:fibroblast
Source: Organ: brain
Disease: glioblastoma
Cell Type: glial cell;
Cellular Products:vimentin; S-100 protein; neuron specific enolase
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Receptors:epidermal growth factor (EGF)
Antigen Expression:Class I antigen expressed
DNA Profile (STR):Amelogenin: X
CSF1PO: 10,11
D13S317: 9
D16S539: 10,12
D5S818: 12,13
D7S820: 11
THO1: 7,8
TPOX: 8
vWA: 15,16
Cytogenetic Analysis:near tetraploid; range 87 to 91; most cells were missing copies of chromosome 10 and had extra copies of chromosome 7
Age: 59 years
Gender: female
Ethnicity: Caucasian
Comments:The DBTRG-O5MG (Denver Brain Tumor Research Group 05) cell line was established from tissue from a patient with glioblastoma multiforme who had been treated with local brain irradiation and multidrug chemotherapy.
The cells are negative for platelet derived growth factor (PDGF), neuronal cell adhesion molecule (NCAM), glial fibrillary acid protein (GFAP) and class II antigen (HLA DR).
No loss of heterozygosity in the p53 tumor suppressor gene was detected.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium:
- fetal bovine serum to a final concentration of 10%
- additional 30 mg/L L-proline
- additional 35 mg/L L-cystine
- additional 3.57 g/L HEPES
- 15 mg/L hypoxanthine
- 1 mg/L adenosine triphosphate
- 10 mg/L adenine
- 1 mg/L thymidine
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium, add fresh 0.25% trypsin, rinse and remove trypsin. Let the flask sit at room temperature (or incubate at 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks.
References: 24397: Kruse CA, et al. Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell. Dev. Biol. 28A: 609-614, 1992. PubMed: 1331021
32274: Koochekpour S, et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57: 5391-5398, 1997. PubMed: 9393765
32550: Debinski W, et al. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. J. Biol. Chem. 271: 22428-22433, 1996. PubMed: 8798406
